<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03440944</url>
  </required_header>
  <id_info>
    <org_study_id>H-37285</org_study_id>
    <secondary_id>H-37285</secondary_id>
    <secondary_id>H-37285</secondary_id>
    <nct_id>NCT03440944</nct_id>
  </id_info>
  <brief_title>Superior Venous Access, Midline vs Ultrasound IVs</brief_title>
  <official_title>Superior Venous Access, Midline vs Ultrasound IVs: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Society for Academic Emergency Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bard Peripheral Vascular, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obtaining intravenous access (IVA) is the most common procedure performed in the emergency&#xD;
      department (ED). Placement of IVA allows for blood work and delivery of intravenous fluids&#xD;
      and medications. The implementation of ultrasound guided peripheral IVs (UGPIV) have allowed&#xD;
      for ultrasound to be used to place an IV into patients with difficult vein access (DVA). An&#xD;
      alternative device to place is a midline catheter (MC). The use of MCs against UGPIV has not&#xD;
      been compared in a randomized study. Aim 1: To determine if UGPIVs have a higher failure rate&#xD;
      than midline catheters within 72 hours of placement. Aim 2: To collect information to perform&#xD;
      a direct cost analysis of UGPIV against that of the midline catheter. Aim 3: Assess patient&#xD;
      satisfaction.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial to determine if the midline catheter is superior to the&#xD;
      ultrasound guided IV with respect to survival at 72 hours.&#xD;
&#xD;
      Aim 1: To determine if UGPIVs have a higher failure rate than midline catheters within 72&#xD;
      hours of placement. There are several reasons why UGPIVs may fail. UGPIVs are shorter than&#xD;
      midline catheters, and shorter catheters may fail due to infiltration which can be a result&#xD;
      of malposition as well as having the catheter pull out of the vessel. It is being&#xD;
      hypothesized that by using a midline catheter with a guidewire for placement with additional&#xD;
      catheter length placed into the vessel, midlines will be superior to UGP\Vs with regards to&#xD;
      survival time of the catheter. The investigators will assess catheter survival daily until 72&#xD;
      hours (when UGPIV are recommended to be changed). The total lifetime of the midline catheters&#xD;
      will be recorded.&#xD;
&#xD;
      Aim 2: To perform a direct cost analysis of UGPIV against that of the midline catheter. This&#xD;
      study will not be large enough to complete a robust cost effectiveness analysis to compare&#xD;
      UGPIV to mid line catheters. As a part of this study the investigators will collect&#xD;
      information including but not limited to: the number of catheters used for IVA attempts, time&#xD;
      for placement of each device complications, and need for additional IVA during&#xD;
      hospitalization.&#xD;
&#xD;
      Aim 3: For patients that remain hospitalized at 72 hours a satisfaction survey will be&#xD;
      administered to determine patient experience and preference for the type of vascular access&#xD;
      that they receive.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    The study was stopped after a pause due to COVID-19 policies and new published evidence about&#xD;
    the effectiveness of the interventon.&#xD;
  </why_stopped>
  <start_date type="Actual">April 23, 2018</start_date>
  <completion_date type="Actual">January 25, 2021</completion_date>
  <primary_completion_date type="Actual">January 25, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized to one of two therapies, peripheral ultrasound IV or midline</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Given the devices are different we will not be able to mask.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Device Failures Within 72 Hours</measure>
    <time_frame>72 hours after device placement</time_frame>
    <description>Total number and percentage of device failures within 72 hours of placement based on midline and ultrasound guided peripheral IV catheter. Medical record review and in person visits with medical treatment teams and patients were used to assess if device failure occurred within 72 hours. Device failure was determined by needing to have any device replaced or removed for clinical care.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>IV Catheter Insertion Time</measure>
    <time_frame>from catheter insertion</time_frame>
    <description>The time it takes to insert the IV catheter will be documented in minutes for each study participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Replacement Catheters</measure>
    <time_frame>from catheter insertion up to 30 days</time_frame>
    <description>The total number of replacement IV catheters will be documented. This will be assessed based on each group (Ultrasound Guided Peripheral IV Catheter and Midline Catheter).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catheter Related Costs</measure>
    <time_frame>from catheter insertion up to 30 days</time_frame>
    <description>The mean costs per patient associated with the placement and replacement of catheters for each participant will be calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>72 hours after catheter insertion</time_frame>
    <description>Participant experience and satisfaction will be assessed with a short survey that will be given to participants who stay at least 72 hours after catheter insertion.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Vascular Access Complication</condition>
  <condition>Ultrasound Therapy; Complications</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guided Peripheral IV Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.88cm in length.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midline Catheter</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound Guided Peripheral IV Catheter</intervention_name>
    <description>Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
    <arm_group_label>Ultrasound Guided Peripheral IV Catheter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Midline Catheter</intervention_name>
    <description>Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
    <arm_group_label>Midline Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient at least 18 years of age being treated in the emergency department at Boston&#xD;
             Medical Center&#xD;
&#xD;
          -  Standard IVA cannot be obtained by two qualified ER staff&#xD;
&#xD;
          -  Have an upper extremity (left or right arm) that can accept a deep venous IV&#xD;
&#xD;
          -  Clinical team believes the patient is likely to require inpatient admission at time of&#xD;
             needing IV access&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Able to provide consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient expected to be discharged from the emergency department or discharged from the&#xD;
             hospital within 1 nights stay.&#xD;
&#xD;
          -  Prisoner&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Requires central line or midline catheter as an expected requirement of care&#xD;
&#xD;
          -  Patients who are expected to require medication that is not approved for&#xD;
             administration via a peripherally guided IV or midline as defined by hospital pharmacy&#xD;
             guidelines.&#xD;
&#xD;
          -  Patients known to have bacteremia or have a high suspicion of bacteremia&#xD;
&#xD;
          -  The patient is known or is suspected to be allergic to materials contained in the&#xD;
             device&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Pare, MD MHS RDMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 11, 2018</study_first_submitted>
  <study_first_submitted_qc>February 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <results_first_submitted>March 10, 2021</results_first_submitted>
  <results_first_submitted_qc>April 3, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 29, 2021</results_first_posted>
  <last_update_submitted>April 3, 2021</last_update_submitted>
  <last_update_submitted_qc>April 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vascular access</keyword>
  <keyword>midline cather</keyword>
  <keyword>ultrasound guided IV</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 29, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT03440944/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Ultrasound Guided Peripheral IV Catheter</title>
          <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
        </group>
        <group group_id="P2">
          <title>Midline Catheter</title>
          <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>No Acceptable Vasculature</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Only patients that received Ultrasound Guided Peripheral IV or Midline Catheter underwent analysis.</population>
      <group_list>
        <group group_id="B1">
          <title>Ultrasound Guided Peripheral IV Catheter</title>
          <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.88cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
        </group>
        <group group_id="B2">
          <title>Midline Catheter</title>
          <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="8"/>
            <count group_id="B2" value="8"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42" lower_limit="36" upper_limit="58"/>
                    <measurement group_id="B2" value="53" lower_limit="43" upper_limit="62"/>
                    <measurement group_id="B3" value="49" lower_limit="38" upper_limit="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Device Failures Within 72 Hours</title>
        <description>Total number and percentage of device failures within 72 hours of placement based on midline and ultrasound guided peripheral IV catheter. Medical record review and in person visits with medical treatment teams and patients were used to assess if device failure occurred within 72 hours. Device failure was determined by needing to have any device replaced or removed for clinical care.</description>
        <time_frame>72 hours after device placement</time_frame>
        <population>Patients who completed therapy within 72 hours were considered non-failure</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Peripheral IV Catheter</title>
            <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
          </group>
          <group group_id="O2">
            <title>Midline Catheter</title>
            <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Failures Within 72 Hours</title>
          <description>Total number and percentage of device failures within 72 hours of placement based on midline and ultrasound guided peripheral IV catheter. Medical record review and in person visits with medical treatment teams and patients were used to assess if device failure occurred within 72 hours. Device failure was determined by needing to have any device replaced or removed for clinical care.</description>
          <population>Patients who completed therapy within 72 hours were considered non-failure</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Device Failure within 72 hours</title>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Device Failure within 72 hours</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>IV Catheter Insertion Time</title>
        <description>The time it takes to insert the IV catheter will be documented in minutes for each study participant.</description>
        <time_frame>from catheter insertion</time_frame>
        <population>Time taken to place each device</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Peripheral IV Catheter</title>
            <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
          </group>
          <group group_id="O2">
            <title>Midline Catheter</title>
            <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
          </group>
        </group_list>
        <measure>
          <title>IV Catheter Insertion Time</title>
          <description>The time it takes to insert the IV catheter will be documented in minutes for each study participant.</description>
          <population>Time taken to place each device</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="7" upper_limit="13"/>
                    <measurement group_id="O2" value="17.5" lower_limit="14" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Replacement Catheters</title>
        <description>The total number of replacement IV catheters will be documented. This will be assessed based on each group (Ultrasound Guided Peripheral IV Catheter and Midline Catheter).</description>
        <time_frame>from catheter insertion up to 30 days</time_frame>
        <population>Number of additional IV (including Midline) catheters placed</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Peripheral IV Catheter</title>
            <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.88cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
          </group>
          <group group_id="O2">
            <title>Midline Catheter</title>
            <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Replacement Catheters</title>
          <description>The total number of replacement IV catheters will be documented. This will be assessed based on each group (Ultrasound Guided Peripheral IV Catheter and Midline Catheter).</description>
          <population>Number of additional IV (including Midline) catheters placed</population>
          <units>additional IV access devices</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Catheter Related Costs</title>
        <description>The mean costs per patient associated with the placement and replacement of catheters for each participant will be calculated.</description>
        <time_frame>from catheter insertion up to 30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Peripheral IV Catheter</title>
            <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
          </group>
          <group group_id="O2">
            <title>Midline Catheter</title>
            <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
          </group>
        </group_list>
        <measure>
          <title>Catheter Related Costs</title>
          <description>The mean costs per patient associated with the placement and replacement of catheters for each participant will be calculated.</description>
          <units>US Dollars</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="8"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.25" spread="21.95"/>
                    <measurement group_id="O2" value="28.88" spread="4.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Satisfaction</title>
        <description>Participant experience and satisfaction will be assessed with a short survey that will be given to participants who stay at least 72 hours after catheter insertion.</description>
        <time_frame>72 hours after catheter insertion</time_frame>
        <population>Patients who stayed for 72 hours, preference to have midline over ultrasound guided peripheral IV catheter. Patients discharged prior to 72 hours of therapy are not included in the reported results. For the Midline Catheter arm only 3 participants stayed at least 72 hours; 5 participants did not complete the satisfaction survey.</population>
        <group_list>
          <group group_id="O1">
            <title>Ultrasound Guided Peripheral IV Catheter</title>
            <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
          </group>
          <group group_id="O2">
            <title>Midline Catheter</title>
            <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Satisfaction</title>
          <description>Participant experience and satisfaction will be assessed with a short survey that will be given to participants who stay at least 72 hours after catheter insertion.</description>
          <population>Patients who stayed for 72 hours, preference to have midline over ultrasound guided peripheral IV catheter. Patients discharged prior to 72 hours of therapy are not included in the reported results. For the Midline Catheter arm only 3 participants stayed at least 72 hours; 5 participants did not complete the satisfaction survey.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="8"/>
                <count group_id="O2" value="3"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Prefer Midline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unsure</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Within 30 days of IV or Midline device placement</time_frame>
      <desc>Adverse Event included device failure or required replacement.</desc>
      <group_list>
        <group group_id="E1">
          <title>Ultrasound Guided Peripheral IV Catheter</title>
          <description>Patients if randomized to this group will receive a standard ultrasound guided peripheral IV. The IV is 4.77cm in length.&#xD;
Ultrasound Guided Peripheral IV Catheter: Patients randomized to this arm will receive an ultrasound guided peripheral IV catheter.</description>
        </group>
        <group group_id="E2">
          <title>Midline Catheter</title>
          <description>Patients if randomized to this group will receive a midline catheter. The catheter is 10cm in length.&#xD;
Midline Catheter: Patients randomized to this group will receive a midline catheter. The catheter is 10cm in length.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="8"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Device Failure</sub_title>
                <description>Device failure due to either pain, swelling, being dislodged, infiltration, or other failure such as inability to provide medications.</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="8"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="8"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joseph Pare, MD</name_or_title>
      <organization>Boston University School of Medicine</organization>
      <phone>6174144925</phone>
      <email>Joseph.pare@bmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

